DSM’s new venture Hologram Sciences plans to run a blood sugar management trial in Singapore to study how personalised approaches can help address pre-diabetes concerns, we can exclusively reveal.
Pre-diabetes concept: Blood sugar management trial in Singapore revealed by DSM-backed Hologram Sciences nutraingredients.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nutraingredients.com Daily Mail and Mail on Sunday newspapers.
NanoPin Technologies Founder s Study Demonstrates Greater Accuracy in Detecting TB in Infants biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
NanoPin Technologies Founder s Study Demonstrates Greater Accuracy in Detecting TB in Infants
Advanced diagnostics designed to mitigate the enduring TB epidemic
Accurate detection platform has applications for COVID-19, HIV, and other infectious diseases
News provided by
Share this article
Share this article
NEW ORLEANS, May 19, 2021 /PRNewswire/ NanoPin Technologies Inc, a biotechnology company focused on developing advanced diagnostics to improve the lives of millions of individuals affected by infectious diseases worldwide, announced the release of a scientific study conducted by founder Tony Hu, Ph.D. Dr. Hu is a professor and Weatherhead Presidential Chair in Biotechnology Innovation at the Tulane University School of Medicine.